115 related articles for article (PubMed ID: 17765993)
1. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses.
Opitz L; Lehmann S; Zimmermann A; Reichl U; Wolff MW
J Biotechnol; 2007 Sep; 131(3):309-17. PubMed ID: 17765993
[TBL] [Abstract][Full Text] [Related]
2. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
[TBL] [Abstract][Full Text] [Related]
3. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
Opitz L; Lehmann S; Reichl U; Wolff MW
Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
[TBL] [Abstract][Full Text] [Related]
4. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
[TBL] [Abstract][Full Text] [Related]
5. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography.
Opitz L; Hohlweg J; Reichl U; Wolff MW
J Virol Methods; 2009 Nov; 161(2):312-6. PubMed ID: 19591872
[TBL] [Abstract][Full Text] [Related]
6. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
He C; Yang Z; Tong K
J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
[TBL] [Abstract][Full Text] [Related]
7. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
Vester D; Rapp E; Gade D; Genzel Y; Reichl U
Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
[TBL] [Abstract][Full Text] [Related]
9. Downstream processing of MDCK cell-derived equine influenza virus.
Nayak DP; Lehmann S; Reichl U
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):75-81. PubMed ID: 16009601
[TBL] [Abstract][Full Text] [Related]
10. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
[TBL] [Abstract][Full Text] [Related]
11. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification.
Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U
Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807
[TBL] [Abstract][Full Text] [Related]
12. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
13. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.
Schwarzer J; Rapp E; Hennig R; Genzel Y; Jordan I; Sandig V; Reichl U
Vaccine; 2009 Jul; 27(32):4325-36. PubMed ID: 19410619
[TBL] [Abstract][Full Text] [Related]
14. [Type and subtype distribution of influenza virus and genetic evolution of hemagglutinin in Shanghai area in duration of 2004 - 2008].
Yang JX; Ju LW; Jiang LF; Shi Q; Jiang QW; Zhang YY; Zhou YB; Shen HG; Tan YY
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):305-8. PubMed ID: 19534952
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand.
Chutinimitkul S; Chieochansin T; Payungporn S; Samransamruajkit R; Hiranras T; Theamboonlers A; Poovorawan Y
Virus Res; 2008 Mar; 132(1-2):122-31. PubMed ID: 18160168
[TBL] [Abstract][Full Text] [Related]
17. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography.
Wolff MW; Siewert C; Hansen SP; Faber R; Reichl U
Biotechnol Bioeng; 2010 Oct; 107(2):312-20. PubMed ID: 20506129
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of human influenza virus in Tehran, Iran.
Soltani Z; Hosseini M; Shahidi M; Hedayati M; Kheiri MT
Intervirology; 2009; 52(2):63-7. PubMed ID: 19401630
[TBL] [Abstract][Full Text] [Related]
19. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns.
Kalashnikova I; Ivanova N; Tennikova T
Anal Chem; 2008 Mar; 80(6):2188-98. PubMed ID: 18271603
[TBL] [Abstract][Full Text] [Related]
20. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France.
Falchi A; Arena C; Andreoletti L; Jacques J; Leveque N; Blanchon T; Lina B; Turbelin C; Dorléans Y; Flahault A; Amoros JP; Spadoni G; Agostini F; Varesi L
J Clin Virol; 2008 Feb; 41(2):148-51. PubMed ID: 18069055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
